First thing’s first, we should be clear that we are optimists about the potential of AI to accelerate research in bio and have no sympathy with calls to ‘pause AI’. We think the kind of therapeutic work companies like @profluentbio are doing will change lives for the better.

→ View original post on X — @nathanbenaich,